Wakobo-ti-Kodro: Improving Identification of Pregnancy at Risk of Obstetric Complications at Community Level
Launched by ALLIANCE FOR INTERNATIONAL MEDICAL ACTION · Sep 23, 2024
Trial Information
Current as of July 30, 2025
Completed
Keywords
ClinConnect Summary
The Wakobo-ti-Kodro trial is focused on improving the health of pregnant women in a region where many face serious risks during pregnancy and childbirth. The goal of the study is to train traditional birth attendants to better identify and monitor high-risk pregnancies, integrate them into the healthcare system, and use a smartphone app designed to support their work. By doing this, the trial aims to increase the number of women who receive care at health facilities and ultimately improve the safety of deliveries in the Bimbo district near the capital of the Central African Republic.
To participate in this study, pregnant women living in the area and visiting the health facilities involved are eligible, as long as they give their consent. The trial is also looking for traditional birth attendants, health workers, community health workers, community representatives, and women who have given birth or are pregnant, all from the study area, to share their experiences and feedback. Participants can expect to be part of a program that seeks to make pregnancy safer and improve health care in their community.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria for the main study (quasi-experimental study with a before-after approach)
- • Aggregated data of pregnant women, regardless of the age of their pregnancy, and
- • attending the health facilities included in the study
- Inclusion Criteria for participating in the observational cohort:
- • Being a pregnant woman residing in the study area and
- • attending the health facilities included in the study and
- • with a given individual consent.
- Inclusion Criteria for participating in the sub-study on intervention's acceptability and feasibility:
- • traditional birth attendants (TBAs) or
- • health workers working in health facilities or
- • community health workers or
- • community representatives or
- • women who have already given birth or pregnant women or their husbands AND
- • All with a given individual consent AND
- • All being part of the study area.
About Alliance For International Medical Action
The Alliance for International Medical Action (AIM) is a global non-profit organization dedicated to improving healthcare access and outcomes in underserved populations worldwide. With a strong focus on clinical research and trials, AIM collaborates with local health authorities, NGOs, and international partners to address public health challenges, particularly in regions affected by conflict and natural disasters. By leveraging innovative methodologies and a commitment to ethical standards, AIM aims to generate evidence-based solutions that enhance the efficacy of medical interventions, ultimately striving to promote health equity and improve the quality of life for vulnerable communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bimbo, Bangui, Central African Republic
Patients applied
Trial Officials
Richard Ngbale, Pr
Principal Investigator
Faculté des sciences de la santé, Bangui
Renaud Becquet
Principal Investigator
Institut National de la Santé Et de la Recherche Médicale, France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported